Host Genetic Variants in the Pathogenesis of Hepatitis C

Direct-acting antiviral drugs (DAAs) are currently replacing antiviral therapy for Hepatitis C infection. Treatment related side effects are even worse and the emergence of resistant viruses must be avoided because of the direct-antiviral action. Altogether it remains a challenge to take treatment d...

Descripción completa

Detalles Bibliográficos
Autores principales: Rau, Monika, Baur, Katharina, Geier, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528266/
https://www.ncbi.nlm.nih.gov/pubmed/23342360
http://dx.doi.org/10.3390/v4123281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528266/
https://www.ncbi.nlm.nih.gov/pubmed/23342360
http://dx.doi.org/10.3390/v4123281

Ejemplares similares